Edition:
United States

Fate Therapeutics Inc (FATE.A)

FATE.A on American Stock Exchange

17.56USD
25 Apr 2019
Change (% chg)

$0.72 (+4.28%)
Prev Close
$16.84
Open
$17.04
Day's High
$17.56
Day's Low
$17.04
Volume
500
Avg. Vol
1,075
52-wk High
$18.97
52-wk Low
$8.35

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $170.63
Shares Outstanding(Mil.): 41.42
Dividend: --
Yield (%): --

Financials

  FATE.A Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.96 -- --
ROI: -72.35 8.91 13.83
ROE: -93.05 10.06 15.25

Earnings vs. Estimates